Osteonic (Korea) Today

226400 Stock  KRW 5,100  60.00  1.16%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 37

 
High
 
Low
Below Average
Osteonic is trading at 5100.00 as of the 27th of November 2024, a 1.16 percent decrease since the beginning of the trading day. The stock's open price was 5160.0. Osteonic has about a 37 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Osteonic Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of September 2024 and ending today, the 27th of November 2024. Click here to learn more.
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. Osteonic Co., Ltd. was founded in 2012 and is based in Seoul, South Korea. OSTEONIC is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 8.45 M outstanding shares. More on Osteonic Co

Moving together with Osteonic Stock

  0.83246710 TR BiofabPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Osteonic Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Osteonic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Osteonic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEODong Lee
Business ConcentrationHealth Care Equipment & Supplies, Healthcare (View all Sectors)
Osteonic Co (226400) is traded on KOSDAQ in Korea and employs 6 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 28.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Osteonic's market, we take the total number of its shares issued and multiply it by Osteonic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Osteonic operates under Healthcare sector and is part of Health Care Equipment & Supplies industry. The entity has 8.45 M outstanding shares. Osteonic Co has accumulated about 9.43 B in cash with 2.95 B of positive cash flow from operations.
Check Osteonic Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Osteonic is W28.49 Billion. Osteonic has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Osteonic Ownership Details

Osteonic Risk Profiles

Although Osteonic's alpha and beta are two of the key measurements used to evaluate Osteonic's performance over the market, the standard measures of volatility play an important role as well.

Osteonic Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Osteonic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run ETFs Now

   

ETFs

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module

Osteonic Corporate Management

Elected by the shareholders, the Osteonic's board of directors comprises two types of representatives: Osteonic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Osteonic. The board's role is to monitor Osteonic's management team and ensure that shareholders' interests are well served. Osteonic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Osteonic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Seok ChoiAssistant Managing DirectorProfile
Seok YooInternal AuditorProfile
Min LeeAssistant Managing DirectorProfile
Tae KimAssistant Managing DirectorProfile
Hyeon ChoiDirectorProfile

Other Information on Investing in Osteonic Stock

Osteonic financial ratios help investors to determine whether Osteonic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Osteonic with respect to the benefits of owning Osteonic security.